Coverage
-
August 30, 2018
Purdue Pharma LP has agreed to pay Assertio Therapeutics Inc., formerly known as Depomed Inc., $62 million in cash to settle claims in New Jersey federal court that Purdue's blockbuster opioid painkiller OxyContin infringed two of Assertio's patents.
1 other articles on this case.
View all »